TPTX - Turning Point Therapeutics Inc. (TPTX) CEO Athena Countouriotis on Q4 2020 Results - Earnings Call Transcript
Turning Point Therapeutics, Inc. (TPTX) Q4 2020 Results Earnings Conference Call March 01, 2021, 4:30 pm ET Company Participants Jim Mazzola - Senior Vice President, Communication and Investor Relations Athena Countouriotis - President, Chief Executive Officer Yi Larson - Executive Vice President, Chief Financial Officer Conference Call Participants Michael Schmidt - Guggenheim Corinne Jenkins - Goldman Sachs David Nierengarten - Wedbush Securities Matt Biegler - Oppenheimer Nick Abbott - Wells Fargo Zegbeh Jallah - ROTH Capital Partners Silvan Türkcan - JMP Securities Arlinda Lee - Canaccord Presentation Operator Ladies and gentlemen, thank you for standing by and welcome to the Turning Point Therapeutics' fourth quarter 2020 conference call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions]. I would now like to hand the conference to your speaker today, Mr. Jim Mazzola, Head of Investor Relations. Thank
For further details see:
Turning Point Therapeutics, Inc. (TPTX) CEO Athena Countouriotis on Q4 2020 Results - Earnings Call Transcript